
Mepresso I 125mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Methylprednisolone (125mg)
Overview Mepresso I 125mg Injection
Solu-Steroid 125mg Injection, a corticosteroid medication, treats various conditions including inflammatory joint diseases, bronchial asthma, severe anaphylaxis, and dermatological or ophthalmological ailments. Administered intravenously, intra-articularly, or intramuscularly by a physician, the dosage is individualized based on the specific condition and symptom severity. Home administration requires thorough physician instruction. Adhere strictly to the prescribed dosage; increasing it won't hasten recovery but elevates the risk of adverse effects. Maintain consistent use, even during symptom remission; abrupt cessation can worsen the underlying condition, necessitating gradual discontinuation. Common side effects include nausea, headache, vertigo, diaphoresis, and peripheral edema. Your physician can help manage these effects. Corticosteroids weaken the immune system; avoid contact with contagious individuals (measles, chickenpox, influenza) and live vaccines. Growth retardation in children is a potential concern. Prior to treatment, disclose any pre-existing osteoporosis, psychiatric conditions, hypertension, hepatic impairment, or diabetes (as this medication can elevate blood glucose levels, potentially exacerbating diabetes). Inform your doctor about all other medications to prevent harmful drug interactions. Disclose pregnancy, pregnancy intentions, or breastfeeding. Prolonged use mandates regular monitoring of blood glucose, blood pressure, bone mineral density, and ophthalmological evaluations.
Uses of Mepresso I 125mg Injection
Management of allergic reactions | Systemic lupus erythematosus (SLE) management | Skin condition treatment | Ophthalmologic disease therapy | Rheumatic disease care
Major Benefits of Mepresso I 125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Mepresso I 125mg Injection:
- Nausea
- Behavioral changes
- Sweating
- Edema (swelling)
- Mood changes
- Upset stomach
- Thinning of skin
- Increased risk of infection
- Reduction in bone density
How to use Mepresso I 125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Mepresso I 125mg Injection works:
Dexamethasone 125mg Injection, a corticosteroid medication, suppresses the synthesis of inflammatory mediators, thereby alleviating symptoms such as redness and swelling associated with allergic responses.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mepresso I 125mg Injection and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Mepresso I 125mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Mepresso I 125mg Injection with breastfeeding are unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Administering Mepresso I 125mg Injection may induce adverse reactions that could impair driving capabilities. Potential side effects include dizziness, vertigo, visual disturbances, and tiredness, all of which can negatively impact driving performance.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Mepresso I 125mg Injection is considered safe. No dosage alteration is typically necessary. Nevertheless, consultation with a physician is advised if you have pre-existing kidney conditions.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mepresso I 125mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mepresso I 125mg Injection :
Omit a Mepresso I 125mg Injection dose? Seek medical advice.
Facts to Know About Mepresso I 125mg Injection
| Label | Value |
|---|---|
| Chemical Category | Corticosteroids |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
